Novartis' Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera Post author:Sam Post published:January 25, 2018 Post category:BioPharma The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace You Might Also Like Vanda Pharmaceuticals’ Hetlioz Shows Promise for Treating Jet Lag March 4, 2018 Juno Appoints To Board Of Directors May 22, 2017 Two Former Ariad Directors Charged With Insider Trading June 27, 2017
